study,site_id,country,region,overall_priority,overall_risk_score,safety_risk,dq_risk,performance_risk,top_action,coordinator_synthesis,estimated_impact
Study_1,Site 17,ESP,EMEA,HIGH,0.9,HIGH,CRITICAL,CRITICAL,URGENT: Expedite SAE review - regulatory timeline at risk,"Executive Summary: Site 17's current status indicates a High Priority due to critical issues in Safety, Data Quality, and Performance. The primary concern is the absence of 16 CRF pages, which raises a data completeness issue (DQ), potentially affecting regulatory submission and site operation. Top action required is to promptly locate and complete the missing documentation for regulatory compliance and smooth site operations.",Significant - Timeline or data quality at risk
Study_24,Site 888,DEU,EMEA,CRITICAL,1.0,CRITICAL,CRITICAL,CRITICAL,URGENT: Expedite SAE review - regulatory timeline at risk,"Executive Summary: Site 888 faces a critical situation due to numerous safety reviews pending regulatory submission (29 SAE), uncompleted visits (10) potentially leading to protocol deviation risks, and critical performance issues. The primary concern is the urgent need for addressing these safety and performance concerns to ensure compliance and the top action should be prioritizing completion of pending reviews, visits, and resolving performance issues.

Recommendation: Immediately address the",High - Immediate regulatory or patient safety impact
Study_1,Site 27,CHN,ASIA,CRITICAL,1.0,CRITICAL,CRITICAL,CRITICAL,URGENT: Expedite SAE review - regulatory timeline at risk,"Executive Summary: Site 27 operations face a CRITICAL status due to pending Safety reviews, performance issues, and a critical data quality situation that is within acceptable parameters. The primary concern lies in the safety reviews and the associated 40 SAE findings awaiting regulatory submission. The top action required is to expedite the regulatory submission process for these safety reviews to ensure operational continuity and maintain safety standards.

Top Priority Action: Expedite the r",High - Immediate regulatory or patient safety impact
